Correlation Between Tscan Therapeutics and CervoMed

Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and CervoMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and CervoMed into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tscan Therapeutics and CervoMed, you can compare the effects of market volatilities on Tscan Therapeutics and CervoMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of CervoMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and CervoMed.

Diversification Opportunities for Tscan Therapeutics and CervoMed

0.02

Correlation Coefficient

Tscan Therapeutics  CervoMed

Significant diversification

The 3 months correlation between Tscan and CervoMed is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and CervoMed in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CervoMed and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with CervoMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CervoMed has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and CervoMed go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and CervoMed

Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the CervoMed. In addition to that, Tscan Therapeutics is 1.84 times more volatile than CervoMed. It trades about -0.11 of its total potential returns per unit of risk. CervoMed is currently generating about 0.01 per unit of volatility. If you would invest  956.00  in CervoMed on August 26, 2025 and sell it today you would lose (29.00) from holding CervoMed or give up 3.03% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Tscan Therapeutics  vs.  CervoMed

Tscan Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

CervoMed

Risk-Adjusted Performance

Weakest

Over the last 90 days CervoMed has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, CervoMed is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Tscan Therapeutics and CervoMed

The main advantage of trading using opposite Tscan Therapeutics and CervoMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, CervoMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CervoMed will offset losses from the drop in CervoMed's long position.

The idea behind Tscan Therapeutics and CervoMed pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.